BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2493405)

  • 1. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model.
    Doody KJ; Dunn RC; Buttram VC
    Fertil Steril; 1989 Mar; 51(3):509-12. PubMed ID: 2493405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of intraperitoneally administered calcium channel blockade and recombinant tissue plasminogen activator to prevent adhesion formation in an animal model.
    Dunn RC; Steinleitner AJ; Lambert H
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1327-30. PubMed ID: 1903594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasminogen activator in adhesion prevention.
    Menzies D; Ellis H
    Surg Gynecol Obstet; 1991 May; 172(5):362-6. PubMed ID: 1902993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of varying days of tissue plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model.
    Dunn RC; Mohler M
    J Surg Res; 1993 Mar; 54(3):242-5. PubMed ID: 8474240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of tissue plasminogen activator and carboxymethylcellulose on adhesion reformation in rabbits.
    Gehlbach DL; O'Hair KC; Parks AL; Rosa C
    Int J Fertil Menopausal Stud; 1994; 39(3):172-6. PubMed ID: 7920754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of melatonin and hyaluronate/carboxymethylcellulose membrane in preventing adhesion reformation following adhesiolysis in a rat uterine model.
    Attar R; Yildirim G; Kumbak B; Ficicioglu C; Demirbag S; Yesildaglar N
    J Obstet Gynaecol Res; 2011 Feb; 37(2):125-31. PubMed ID: 21159036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator.
    Orita H; Fukasawa M; Girgis W; diZerega GS
    Int J Fertil; 1991; 36(3):172-7. PubMed ID: 1678373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intra-abdominal administration of ligustrazine nanoparticles nano spray on postoperative peritoneal adhesion in rat model.
    Yan S; Yue YZ; Zeng L; Yue J; Li WL; Mao CQ; Yang L
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1942-50. PubMed ID: 26419644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator.
    Menzies D; Ellis H
    J R Soc Med; 1989 Sep; 82(9):534-5. PubMed ID: 2507782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adhesions: from formation to prevention.
    Alpay Z; Saed GM; Diamond MP
    Semin Reprod Med; 2008 Jul; 26(4):313-21. PubMed ID: 18756408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator and adhesion prevention.
    Dunn RC
    Prog Clin Biol Res; 1993; 381():213-20. PubMed ID: 8316565
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of diazeniumdiolates (NONOates) and methylene blue on the reduction of postoperative adhesion in rats.
    Cetin M; Duran B; Demirkoprulu N; Guvenal T; Erden O; Cetin A
    Gynecol Obstet Invest; 2004; 57(4):186-90. PubMed ID: 14752212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of urokinase in the prevention of intraperitoneal adhesions; role of blood in their formation.
    Birkenfeld A; Schenker JG
    Ann Chir Gynaecol; 1983; 72(5):246-9. PubMed ID: 6660826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro.
    Qin F; Ma Y; Li X; Wang X; Wei Y; Hou C; Lin S; Hou L; Wang C
    Int J Nanomedicine; 2015; 10():3699-716. PubMed ID: 26056449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental adhesion prophylaxis with recombinant tissue plasminogen activator.
    Vipond MN; Whawell SA; Scott-Coombes DM; Thompson JN; Dudley HA
    Ann R Coll Surg Engl; 1994 Nov; 76(6):412-5. PubMed ID: 7702327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasminogen activators during healing after uterine serosal lesioning in the rat.
    Rout UK; Diamond MP
    Fertil Steril; 2003 Jan; 79(1):138-45. PubMed ID: 12524078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery.
    ;
    Fertil Steril; 2007 Jul; 88(1):21-6. PubMed ID: 17613300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion formation and prevention after peritoneal injury and repair in the rabbit.
    McDonald MN; Elkins TE; Wortham GF; Stovall TG; Ling FW; McNeeley SG
    J Reprod Med; 1988 May; 33(5):436-9. PubMed ID: 3290475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of peritoneal adhesions: a promising role for gene therapy.
    Atta HM
    World J Gastroenterol; 2011 Dec; 17(46):5049-58. PubMed ID: 22171139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention effects of cryptotanshinone nanoemulsion on postoperative peritoneal adhesions.
    Chengxi W; Rishuo G; QuLiang G; Laiyou W; Lianbing H; Linghao Q
    Drug Dev Ind Pharm; 2019 May; 45(5):695-702. PubMed ID: 30560692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.